Suppr超能文献

无肾脏替代治疗的终末期肾衰竭的治疗

Treatment of End-stage Kidney Failure without Renal Replacement Therapy.

作者信息

Hole Barnaby, Tonkin-Crine Sarah, Caskey Fergus J, Roderick Paul

机构信息

Department of Renal Medicine, North Bristol NHS Trust, Southmead Hospital, Bristol, United Kingdom.

Nuffield Department of Primary Care Health Sciences, University of Oxford, Oxford, United Kingdom.

出版信息

Semin Dial. 2016 Nov;29(6):491-506. doi: 10.1111/sdi.12535. Epub 2016 Aug 25.

Abstract

For the majority of patients with end-stage kidney failure (ESKF) replacement of excretory renal function by dialysis or transplantation (RRT) can extend life and alleviate symptoms. Historically, the availability of RRT has been insufficient and this remains the case for much of the world. However, RRT is now widely available in healthcare systems of higher income countries. Increasing numbers of elderly patients are developing ESKF. RRT in this population is largely by dialysis, comorbidity is high and life expectancy short. Evidence of effectiveness coupled with the burden of treatment among these individuals has raised concerns that health services in high-income countries may have moved from an era of unmet need into one of potential over-treatment. Alongside the requirement to make treatment more patient-centered, this has driven the development of comprehensive conservative care as an alternative approach for older comorbid individuals with ESKF, with the potential for acceptable symptom control and reduced treatment burden. This paper provides a largely UK-perspective on treating ESKF without RRT. Emphasis is on the need for high-quality evidence to inform treatment decisions. Complexities of defining, delivering and improving treatment of ESKF without dialysis care are explored. Quantitative and qualitative evidence are summarized and the relationship with palliative and terminal care examined. A framework is suggested for classifying management of ESKF and recommendations made to improve delivery of nondialysis care in the future. For patients with a poor prognosis, such treatment may not result in significantly different survival or quality of life when compared with dialysis. There is a key need to generate the best possible evidence of person-centered health outcomes associated with the various treatment options for ESKF and to present this to patients in a balanced, personalized way that allows them to make the treatment decision most appropriate for them.

摘要

对于大多数终末期肾衰竭(ESKF)患者而言,通过透析或移植进行肾脏排泄功能替代治疗(RRT)可以延长生命并缓解症状。从历史上看,RRT的可及性一直不足,世界上许多地区目前仍是这种情况。然而,RRT现在在高收入国家的医疗保健系统中已广泛可及。越来越多的老年患者患上了ESKF。该人群的RRT主要通过透析进行,合并症发生率高且预期寿命短。有效性证据以及这些个体的治疗负担引发了人们的担忧,即高收入国家的医疗服务可能已从需求未得到满足的时代进入了潜在过度治疗的时代。除了需要使治疗更加以患者为中心之外,这也推动了综合保守治疗的发展,作为患有ESKF的老年合并症患者的一种替代方法,具有实现可接受的症状控制和减轻治疗负担的潜力。本文主要从英国的视角探讨了不进行RRT治疗ESKF的情况。重点在于需要高质量的证据来为治疗决策提供依据。探讨了在没有透析治疗的情况下定义、提供和改善ESKF治疗的复杂性。总结了定量和定性证据,并研究了其与姑息治疗和终末期护理的关系。提出了一个用于对ESKF管理进行分类的框架,并给出了未来改善非透析治疗提供情况的建议。对于预后较差的患者,与透析相比,这种治疗可能不会在生存或生活质量方面产生显著差异。迫切需要生成与ESKF各种治疗选择相关的、以患者为中心的健康结果的最佳证据,并以平衡、个性化的方式将其呈现给患者,使他们能够做出最适合自己的治疗决策。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验